(FXC) iShares China Large Cap - Ratings and Ratios
Chinese, Large-Cap, Equity, Securities
Description: FXC iShares China Large Cap
The iShares China Large Cap UCITS ETF, ticker symbol FXC, is an investment fund that tracks the Morningstar China TME NR USD Index, providing exposure to large-cap Chinese equities. As a UCITS-compliant ETF, it is designed to be a diversified and regulated investment product, suitable for a broad range of investors.
From a technical analysis perspective, the current price of FXC is 88.47, indicating a potential short-term correction given that it is below its 20-day Simple Moving Average (SMA) of 89.71. However, it is above its 50-day SMA of 87.70, suggesting a longer-term uptrend. The 200-day SMA at 85.43 further supports this bullish outlook. The Average True Range (ATR) of 1.37, or 1.55%, indicates moderate volatility, and the 52-week high and low of 100.01 and 63.05, respectively, highlight the ETFs price range over the past year.
Fundamentally, the ETF has Assets Under Management (AUM) of approximately 970.61 million EUR, indicating a significant investor base and liquidity. As an ETF focused on Chinese large-cap equities, its performance is closely tied to the overall Chinese economy and market sentiment. Given the current economic landscape and the growth prospects of the Chinese market, this ETF is positioned to benefit from any positive developments.
Forecasting the future performance of FXC involves integrating both technical and fundamental analyses. Technically, a breakout above the 20-day SMA and subsequent resistance levels could signal further upside potential, targeting the 52-week high of 100.01. Fundamentally, if the Chinese economy continues to grow and investor sentiment improves, the AUM of the ETF could increase, potentially driving the price higher due to increased demand. Conversely, failure to break through resistance or a downturn in the Chinese economy could lead to a decline. Based on these considerations, a potential short-term target for FXC could be around 92-93, assuming it can break through its current resistance levels, while a longer-term target could be in the range of 100-105, contingent on sustained economic growth and positive market sentiment.
Additional Sources for FXC ETF
FXC ETF Overview
Market Cap in USD | 1,199m |
Category | China Equity |
TER | 0.74% |
IPO / Inception | 2004-10-21 |
FXC ETF Ratings
Growth Rating | -4.94 |
Fundamental | - |
Dividend Rating | 28.2 |
Rel. Strength | 17 |
Analysts | - |
Fair Price Momentum | 88.21 EUR |
Fair Price DCF | - |
FXC Dividends
Dividend Yield 12m | 3.32% |
Yield on Cost 5y | 2.86% |
Annual Growth 5y | -8.24% |
Payout Consistency | 93.0% |
Payout Ratio | % |
FXC Growth Ratios
Growth Correlation 3m | 61.8% |
Growth Correlation 12m | 77.1% |
Growth Correlation 5y | -52.7% |
CAGR 5y | -1.85% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | 0.02 |
Alpha | 21.75 |
Beta | 0.695 |
Volatility | 23.59% |
Current Volume | 10.3k |
Average Volume 20d | 5.4k |
Stop Loss | 86.8 (-3.5%) |
As of July 09, 2025, the stock is trading at EUR 89.94 with a total of 10,303 shares traded.
Over the past week, the price has changed by +0.22%, over one month by -2.05%, over three months by +12.63% and over the past year by +34.01%.
Neither. Based on ValueRay´s Analyses, iShares China Large Cap is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -4.94 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FXC is around 88.21 EUR . This means that FXC is currently overvalued and has a potential downside of -1.92%.
iShares China Large Cap has no consensus analysts rating.
According to our own proprietary Forecast Model, FXC iShares China Large Cap will be worth about 100.9 in July 2026. The stock is currently trading at 89.94. This means that the stock has a potential upside of +12.17%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 100.9 | 12.2% |